Trial Profile
Effectiveness and safety of tenofovir alafenamide for chronic hepatitis B patients
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 16 Sep 2020
Price :
$35
*
At a glance
- Drugs Tenofovir alafenamide (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 14 Sep 2020 Planned number of patients increased from 150 to 650.
- 14 Sep 2020 Planned number of patients changed from 150 to 650.
- 03 Nov 2017 New trial record